Lantheus Holdings (STU:0L8) Cyclically Adjusted Revenue per Share: €13.41 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:0L8 Lantheus Holdings Inc STU:0L8
86 GF Score
Price €87.60
GF Value €79.31
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Lantheus Holdings Cyclically Adjusted Revenue per Share?

Lantheus Holdings STU:0L8 +0.57% 86 Cyclically Adjusted Revenue per Share is €13.41 as of Jun. 2026. GuruFocus rates STU:0L8 with a GF Score™ of 86/100 and a GF Value™ of €79.31 (Fairly Valued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Lantheus Holdings's adjusted revenue per share for the three months ended in Jun. 2026 was €4.945. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €13.41 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Lantheus Holdings's average Cyclically Adjusted Revenue Growth Rate was 10.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 5.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Lantheus Holdings was 5.00% per year. The lowest was 5.00% per year. And the median was 5.00% per year.

As of today (2026-09-17), Lantheus Holdings's current stock price is €87.60. Lantheus Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was €13.41. Lantheus Holdings's Cyclically Adjusted PS Ratio of today is 6.53.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Lantheus Holdings was 9.36. The lowest was 3.70. And the median was 5.88.


Lantheus Holdings  (STU:0L8) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Lantheus Holdings's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=87.60/13.406
=6.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Lantheus Holdings was 9.36. The lowest was 3.70. And the median was 5.88.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Lantheus Holdings Cyclically Adjusted Revenue per Share Related Terms


Lantheus Holdings Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Lantheus Holdings's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lantheus Holdings Cyclically Adjusted Revenue per Share Chart

Lantheus Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.47 9.33 10.44 11.72 12.55

Lantheus Holdings Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.18 12.46 12.66 13.08 13.41

STU:0L8 vs HIMS, AMRX, KNSA: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Lantheus Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lantheus Holdings Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lantheus Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Lantheus Holdings's Cyclically Adjusted PS Ratio falls into.


STU:0L8
86GF Score
Lantheus Holdings Inc STU:0L8
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lantheus Holdings Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Lantheus Holdings's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=4.945/333.9520*333.9520
=4.945

Current CPI (Jun. 2026) = 333.9520.

Lantheus Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 1.783 241.428 2.466
201612 1.822 241.432 2.520
201703 1.978 243.801 2.709
201706 2.075 244.955 2.829
201709 1.741 246.819 2.356
201712 1.756 246.524 2.379
201803 1.702 249.554 2.278
201806 1.823 251.989 2.416
201809 1.940 252.439 2.566
201812 1.914 251.233 2.544
201903 1.915 254.202 2.516
201906 1.896 256.143 2.472
201909 1.915 256.759 2.491
201912 2.011 256.974 2.613
202003 2.053 258.115 2.656
202006 1.390 257.797 1.801
202009 1.134 260.280 1.455
202012 1.181 260.474 1.514
202103 1.134 264.877 1.430
202106 1.243 271.696 1.528
202109 1.280 274.310 1.558
202112 1.674 278.802 2.005
202203 2.658 287.504 3.087
202206 2.965 296.311 3.342
202209 3.342 296.808 3.760
202212 3.769 296.797 4.241
202303 4.138 301.836 4.578
202306 4.162 305.109 4.555
202309 4.199 307.789 4.556
202312 4.697 306.746 5.114
202403 4.863 312.332 5.200
202406 5.185 314.175 5.511
202409 4.719 315.301 4.998
202412 5.297 315.605 5.605
202503 4.956 319.799 5.175
202506 4.744 322.561 4.912
202509 4.856 324.800 4.993
202512 5.270 324.054 5.431
202603 4.904 330.213 4.960
202606 4.945 333.952 4.945

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €13.41 mean?
Lantheus Holdings (STU:0L8) has a Cyclically Adjusted Revenue per Share of €13.41 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Lantheus Holdings and its competitors.
Is Lantheus Holdings' Cyclically Adjusted Revenue per Share too high?
Lantheus Holdings' current Cyclically Adjusted Revenue per Share is €13.41. Overall, Lantheus Holdings has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Lantheus Holdings' Cyclically Adjusted Revenue per Share compare to HIMS and AMRX?
Lantheus Holdings' Cyclically Adjusted Revenue per Share of €13.41 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Lantheus Holdings and its competitors. Lantheus Holdings's current Cyclically Adjusted Revenue per Share is €13.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lantheus Holdings stock overvalued right now?
Based on GuruFocus' analysis, Lantheus Holdings (STU:0L8) is currently considered Fairly Valued. The stock's GF Value™ is €79.31, compared to a current price of €87.60 — trading 10.5% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is €13.41. Lantheus Holdings' overall GF Score™ is 86/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Lantheus Holdings (STU:0L8), the current Cyclically Adjusted Revenue per Share is €13.41 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lantheus Holdings (STU:0L8) Overvalued in 2026?

Based on GuruFocus' analysis, Lantheus Holdings stock appears to be overvalued. The current stock price of €87.60 is trading 10.5% above its estimated GF Value™ of €79.31. GuruFocus considers Lantheus Holdings to be Fairly Valued.

Key valuation signals for STU:0L8:

  • Cyclically Adjusted Revenue per Share: €13.41
  • GF Value™: €79.31 vs. price of €87.60 (10.5% above fair value)
  • GF Score™: 86/100 with 2 warning signs

No single metric tells the full story. See the STU:0L8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lantheus Holdings Business Description

Other Exchanges LNTH:USA1LNTH:Italy
Address 201 Burlington Road, South Building, Bedford, MA, USA, 01730
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
86GF Score

Get the complete analysis for STU:0L8

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€87.60
Price
€79.31
GF Value